Passer au contenu principal

Chemical Entities of Biological Interest Ontology (CHEBI)

Choisissez le vocabulaire dans lequel chercher

aligner
annoter
télécharger

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic polycyclic compound > organic tricyclic compound > organic heterotricyclic compound > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic polycyclic compound > organic tricyclic compound > organic heterotricyclic compound > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic polycyclic compound > organic tricyclic compound > organic heterotricyclic compound > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > polycyclic compound > organic polycyclic compound > organic tricyclic compound > organic heterotricyclic compound > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterotricyclic compound > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterotricyclic compound > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterotricyclic compound > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterotricyclic compound > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organic heteropolycyclic compound > organic heterotricyclic compound > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > heteropolycyclic compound > organic heteropolycyclic compound > organic heterotricyclic compound > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > polycyclic compound > heteropolycyclic compound > organic heteropolycyclic compound > organic heterotricyclic compound > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > heteropolycyclic compound > heterotricyclic compound > organic heterotricyclic compound > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > polycyclic compound > heteropolycyclic compound > heterotricyclic compound > organic heterotricyclic compound > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > oxacycle > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > oxacycle > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > oxacycle > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > oxacycle > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > oxacycle > naphthofuran > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > lactam > ansamycin > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > organonitrogen heterocyclic compound > lactam > ansamycin > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > lactam > ansamycin > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > lactam > ansamycin > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > lactam > ansamycin > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > lactam > ansamycin > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organonitrogen heterocyclic compound > lactam > ansamycin > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > carboxamide > lactam > ansamycin > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > carboxamide > lactam > ansamycin > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > carboxamide > lactam > ansamycin > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > lactam > ansamycin > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > carboxamide > lactam > ansamycin > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > lactam > ansamycin > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > cyclic amide > lactam > ansamycin > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > polyketide > ansamycin > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > polyketide > ansamycin > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > polyketide > ansamycin > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > macrocycle > ansamycin > rifamycins > O-(ADP-D-ribosyl)-rifampicin(2-)

Terme préférentiel

O-(ADP-D-ribosyl)-rifampicin(2-)  

Concept générique

Appartient au groupe

URI

http://data.loterre.fr/ark:/67375/KFP-L8S8X61C-M

Télécharger ce concept :

RDF/XML TURTLE JSON-LD